Fosfluridine tidoxil

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFosfluridine tidoxil
Drug Alias Name磷氟啶酯fosfluridina tidoxilofosfluridine tidoxilfosfluridinum tidoxilumHDP-990006 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsKeratosis, ActinicColorectal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWilex AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWilex AG
Active IndicationsN/A
Inactive IndicationsKeratosis, ActinicColorectal NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A